1. Dana-Farber Cancer Institute, Boston, MA;
2. Veneto Institute of Oncology, IOV–IRCCS, Veneto, Italy;
3. University of Colorado Comprehensive Cancer Center, Aurora, CO;
4. Aix-Marseille University, CHU Timone, Marseille, France;
5. Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland;
6. Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI;
7. Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX;
8. University of Essen and the German Cancer Consortium, Essen, Germany;
9. The College of Medicine, Swansea University, Swansea, United Kingdom;
10. Universitäts Spital Zürich, Zurich, Switzerland;
11. IEO, European Institute of Oncology, IRCCS, Milan, Italy;
12. Cross Cancer Institute, Edmonton, AB, Canada;
13. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;
14. Tasman Oncology Research Ltd, Southport, QLD, Australia;
15. Hospital General Universitario Gregorio Marañon, Madrid, Spain;
16. Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands;
17. Bristol Myers Squibb, Uxbridge, United Kingdom;
18. Bristol Myers Squibb, Princeton, NJ;
19. Memorial Sloan Kettering Cancer Center, New York, NY;
20. The Royal Marsden Hospital, London, United Kingdom;